Skip to main content

Editorial Board


Linda Gummlich, PhD

New Content ItemLinda is a Senior Editor for the BMC Series since July 2018 and the Co-Editor of BMC Cancer. She holds a Master's degree in Molecular Medicine from Friedrich Schiller University in Jena. Before joining BioMed Central, Linda completed her joint PhD in altered protein degradation mechanisms in renal cell carcinomas at the Charite University Hospital and Humboldt University in Berlin and then continued to work for a Berlin-based NGO as programme manager. Here Linda designed, launched and developed a successful programme to integrate refugees into the German labour market. Linda brings great passion to her work on BMC Cancer and BMC Palliative Care while fervently supporting and promoting Open Access and Open Science.

Chiara Cilibrasi, PhD

New Content ItemDr Chiara Cilibrasi is an Associate Editor for the BMC Series and joined in April 2022 after over ten years of research experience. She holds a Master’s degree in Medical Biotechnologies and a PhD in Neuroscience from the University of Milano-Bicocca, where she studied the effect of targeted cell cycle inhibition on glioma stem cells. Following postdoctoral work at the same University, she moved as a Research Fellow to the University of Sussex where she focused on the identification of potential new biomarkers and therapeutic targets in glioblastoma and breast cancer. Chiara actively promotes the publication of open and reproducible research.

Senior Editorial Board Members

Tarek Bismar

New Content ItemDr Bismar joined the BMC Cancer Senior Editorial Board in September 2020 and is currently a Professor at the University of Calgary and Adjunct Professor in the Department of Oncology at McGill University. Dr. Bismar is a clinician scientist and urological pathologist working as primary pathologist for signing out genitourinary oncology cases. He is also a consultant for genitourinary pathology and oncology cases for various department members. His research focuses on characterizing novel molecular signatures and biomarkers to infer disease progression, targeting two clinical areas. Firstly, in the active surveillance population where developing signatures that could be clinically implemented to develop personalized protocols for follow-up and re-biopsy of such patients. The second area focuses on advanced castrate resistant and neuroendocrine disease, where Dr. Bismar aims to develop signatures that infer patients at highest risk for developing NEPCA post hormonal therapy. Dr. Bismar lab is funded by Prostate Cancer Canada, Canadian Cancer Society and the prostate Cancer Foundation of USA with many collaborations nationally and internationally.

Yanis Boumber

New Content ItemYanis Boumber, MD, PhD, Associate Professor, Division of Hematology/ Oncology, Section of Thoracic Head and Neck Medical Oncology, at Northwestern University Cancer Center in Chicago. Dr. Boumber has previously worked as Assistant Professor in the Thoracic Section of the Department of Hematology/Oncology at the Fox Chase Cancer Center, Philadelphia, USA. Dr Boumber graduated from the Rostov State Medical University, Russia and qualified as MD in 1999. He received his PhD in cancer biology and molecular biology at the University of Texas MD Anderson Cancer Center and the University of Texas Graduate School of Biomedical Sciences in Houston in 2005. He completed his medicine residency at Good Samaritan hospital, affiliated with Johns Hopkins University in Baltimore in 2010, and medical oncology and hematology fellowship at the University of Texas MD Anderson Cancer Center in 2013.His research interests include the investigation of signaling pathways and biological processes controlled by MSI2 and developing novel therapeutic approaches to target MSI2 in lung cancer. He joined the editorial board of BMC Cancer in 2016 as Deputy Section Editor. He serves as Senior Board Member since August 2020.

Ignacio Casal

New Content ItemDr Ignacio Casal got his PhD in 1984 in the Centro de Biología Molecular (CSIC-Universidad Autónoma de Madrid (Spain)). Post-doctoral fellow (1985-1986) in the Massachusetts Institute of Technology (MIT) (USA). Project leader and research director at INGENASA (1987-2001).  Director of the Biotechnology Program (Spanish National Cancer Research Center (CNIO) (2001-2008) and, currently, scientific investigator at the Spanish Research Council (CSIC). 

Mary Jo Fidler

New Content ItemDr. Fidler is the section chief of medical oncology and associate professor in the Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy at Rush Medical College. Dr. Fidler attended Cornell University in Ithaca, New York for undergraduate work. She received her medical degree from the Albert Einstein College of Medicine in Bronx , New York and then went on to complete her internal medicine residency at the McGaw Medical Center of Northwestern University in Chicago and Fellowship in Hematology/Oncology at Rush University Medical Center. Dr. Fidler specializes in the treatment of thoracic and head and neck cancers. Her translational research interests focus on mechanisms of chemotherapy and radiotherapy resistance, predictors of response to immune check point inhibitors, and cancer cachexia. She has enrolled patients on several clinical trials testing both immune checkpoint inhibitors and targeted therapies. Dr. Fidler is the national principal investigator for the ADURA trial of osimertinib in surgically resected patients with the EGFR activating mutation and the local principal investigator for the ORCHARD trial in the Midwest, which seek to identify the next best treatments for patients with EGFR activating gene mutations that have cancer progression after osimertinib. Dr. Fidler has authored and co-authored several manuscripts, publications and abstracts. She has served on the Boards of Trustees for the Chicago Medical Society and the Illinois State Medical Society and has chaired various advocacy groups through these organizations.

Nicolas Hart

New Content ItemNicolas is a Senior Editorial Board Member of BMC Cancer. As an NHMRC Emerging Leader Fellow and Associate Professor in Cancer Survivorship, his clinical expertise and research focuses on improving outcomes for all people affected by cancer, with a specific interest in people living with advanced or metastatic cancers. His work canvasses oncology and hematology and aims to interrogate (1) survivorship and supportive care issues (i.e., exercise, nutrition, psychosocial, rehabilitation, toxicity management), and (2) cancer outcomes (i.e., tumour biology, disease progression, and overall survival). In recognition of his clinical expertise, he is a member of the World Health Organisation Cancer Rehabilitation Development Group; inaugural Chair of Exercise Oncology for the Multinational Association for Supportive Care in Cancer; and MASCC Terry Langbaum Survivorship Fellow developing principles of survivorship care for people with advanced or metastatic cancers. He has published >100 papers and 2 book chapters (including for the European Society of Medical Oncology).

Sebastien Krug

New Content ItemProfessor Krug  joined the BMC Cancer Senior Editorial Board in 2020 and is currently a Chief Senior Physician in the Department of Gasteroenterology and Hepatology, at Martin Luther University Halle, Germany. There is a Specialist in Internal Medicine and Gastroenterology. Prior to that he completed his residency in Internal Medicine at the Department of Gastroenterology and Endocrinology, Philipps-University of Marburg, Germany. Since 2015 he has been a member of the molecular-genetic research laboratory of Prof. Dr. Patrick Michl where his research focuses on understanding the molecular and genetic characteristics of neuroendocrine tumours. Prof Krug’s research also involves developing new therapeutics and diagnostics for neuroendocrine neoplasms. 

Úna McMenamin

Dr McMenamin is a Lecturer in Population Cancer Research and UKRI Future Leaders Fellow within the Centre for Public Health at Queen’s University Belfast (Northern Ireland, UK). In 2014, she was awarded her PhD in Cancer Epidemiology at Queen’s University Belfast, and prior to this a Masters in Public Health. Currently, Dr McMenamin is leading a UKRI Future Leaders Fellowship focusing on gynaecological cancer, where she is developing robust population-level evidence to inform diagnostic, treatment and surveillance strategies for women with diagnosed with endometrial cancer and its precursor condition; endometrial hyperplasia. Prior to this, Dr McMenamin led a Cancer Research UK Population Research Postdoctoral Fellowship that included research placements at the National Cancer Institute in the Washington DC, United States, and the Belgian Cancer Registry in Brussels, Belgium.

Sam Merriel

New Content ItemSam joined BMC Cancer as Senior Editorial Board Member in September 2020. Sam is a GP practicing in North-West England and an NIHR Academic Clinical Lecturer at the University of Manchester. His main research interests are the prevention and early diagnosis of cancer in primary care and the evaluation and implementation of new diagnostic tests. Sam recently completed his PhD at the University of  Exeter exploring the potential impact of direct access prostate MRI for prostate cancer diagnosis in primary care. Sam is also Associate Editor and Editorial Board Member for the British Journal of General Practice and has been part of expert reference groups for NICE, the National Cancer Research Institute (NCRI), Prostate Cancer UK, Movember and Cancer Research UK.’

Jens Neumann

New Content ItemJens Neumann has been with BMC Cancer since 2013, initially as Associate Editor and since 2020 as Senior Editorial Board Member. He received his doctorate in medicine from the Medical University of Graz, Austria and then completed his training as a specialist in pathology at the University Hospital in Freiburg and at the Institute of Pathology, Ludwig-Maximilians University (LMU) Munich, Germany. Since his habilitation (PhD), he has been working as a professor and senior consultant at the Institute of Pathology, Medical Faculty, LMU Munich. His diagnostic specialties are gastrointestinal and thoracic pathology and his scientific focus are (translational) biomarker studies in gastrointestinal cancer and thoracic oncology.

Senior Editorial Board Members
Tarek Bismar, University of Calgary, Canada 
Ignacio Casal, Centro de Investigaciones Biológicas (CSIC), Spain
Mary Jo Fidler, Rush University Medical Center, USA
Niccola Funel, University of Pisa, Italy
Nicolas Hart, University of Technology Sydney, Australia 
Sebastian Krug, Universitätsklinikum Halle, Germany
Úna McMenamin, Queen’s University Belfast, United Kingdom  
Sam Merriel, University of Manchester, United Kingdom
Jens Neumann, Ludwig-Maximilians-Universität, Germany

Editorial Board Members
Sherif Abdelhamed, St Jude Children’s Research Hospital, USA
Jamshid Abdul Ghafar, French Medical Institute for Mothers and Children (FMIC), Afghanistan
Malak Abedalthagafi, King Fahad Medical City, Saudi Arabia
Ajay Abraham, University of Texas at Austin, USA 
Filippo Acconcia, University Roma TRE, Italy
Arghya Adhikary, University of Calcutta, India
Syed Sameer Aga, King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia
Sumit Agarwal, University of Alabama at Birmingham, USA
Supreet Agarwal, National Cancer Institute (NIH), USA
Atif Ahmed, Children’s Mercy Hospitals and Clinics, USA
Young-Ho Ahn, Ewha Womans University, South Korea
Ke Ai-Wu, Zhongshan Hospital, Fudan University, China
Guntulu Ak, Eskisehir Osmangazi University, Turkey
Wajd Al-Holou, University of Michigan Medical School, USA
Maysa Al-Hussaini, King Hussein Cancer Center, Jordan
Domenico Albano, University of Brescia and Spedali Civili Brescia, Italy
Marliese Alexander, Peter MacCallum Cancer Centre, Australia
Pierpaolo Alongi, Fondazione Istituto G.Giglio, Italy
Stefano Amatori, University of Urbino ‘Carlo Bo’, Italy
Chansik An, National Health Insurance Service Ilsan Hospital, South Korea
Fangmei An, Nanjing Medical University Affiliated Wuxi People's Hospital, China
Kiyohiro Ando, Saitama Cancer Center, Japan
Laura Annaratone, University of Turin, Italy
Takaaki Arigami, Kagoshima University, Japan
Guillermo Armaiz, Ponse Health Science University, USA
Mary E. Aronow, Massachusetts Eye and Ear Infirmary, Harvard Medical School, USA
Sanjeevani Arora, Fox Chase Cancer Center, USA
Tetsuhiko Asao, Juntendo University, Japan
Bruce Ashford, University of Wollongong, Australia
Hassan Ashktorab, Howard University, USA
Djordje Atanackovic, University of Utah, USA
Sunday Azagba, University of Utah, USA
Faisal Aziz, University of Minnesota & Mayo Clinic, United States
Mansi Babbar, GlaxoSmithKline, USA
Sunil Badve, Indiana University, USA
Fabio Bagante, University of Verona, Italy
Xue Bai, Peking University Cancer Hospital, China
Andrei Bakin, Roswell Park Comprehensive Cancer Center, USA
Fátima Baltazar, University of Minho, Portugal
Ramesh Balusu, University of Kansas Medical Center, USA
Oluwaseun Adebayo Bamodu, Taipei Medical University, Taiwan
Sushanta Banerjee, University of Kansas Medical Center and VA Medical Center, USA
Giuseppe Luigi Banna, University of Portsmouth, UK
Joseph Barbi, Roswell Park Cancer Institute, USA
Nuno L Barbosa-Morais, Instituto de Medicina Molecular, Portugal
Ayan Kumar Barui, Chapman University, USA
Mehmet Baysal, Bursa Ali Osman Sönmez Oncology Hospital, Turkey
Tim Beck, Cleveland Clinic, USA
Antonino Belfiore, Policlinico Mater Domini, Italy
Abbes Belkhiri, Vanderbilt University Medical Center, USA
Valentina Belli, Istituto Xazionale Tumor IRCCS Fondazione G. Pascale, Italy
Ibrahim Bello, King Saud University, Saudi Arabia
Marcia Bellon, University of Kansas Medical Center, USA
Adam Berger, Rutgers Cancer Institute of New Jersey, USA
Alfredo Berruti, University of Brescia, Italy
Kinjal Bhadresha, National Institute of Health, USA
Kishor K Bhakat, University of Nebraska Medical Center, USA
Anjana Bhardwaj, MD Anderson Cancer Center, USA
Alok Chandra Bharti, University of Delhi, India
Gh Rasool Bhat, Skims Soura, India
Rebecca Birch, University of Leeds, UK
Kajal Biswas, National Cancer Institute, USA
Marc Bjurlin, New York University, USA
Alessandra Boccaccino, UOC Oncologia Ravenna, AUSL Romagna, Italy
Laura Bonanno, Istituto Oncologico Veneto IOV IRCCS, Italy
Alberto Bongiovanni, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Italy
Signe Borgquist, Aarhus University Hospital, Denmark
Chinmoy Bose, Netaji Subhash Chandra Bose Cancer Hospital, India
Anne-Deborah Bouhnik, Aix Marseille University, France
Maroun Bou Zerdan, SUNY Upstate Medical University Hospital, USA
Yanis Boumber, Northwestern University, USA
Sara Bravaccini, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Italy
Mireille M.J. Broeders, Radboud University Nijmegen Medical Centre, Netherlands
Jean-Phillipe Brosseau, University of Texas Southwestern Medical Center, USA
Adam Brufsky, University of Pittsburgh School of Medicine, USA
Bruce Bunnell, University of North Texas Health Science Center, USA
Hakan Buyukhatipoglu, Harran University School of Medicine, Turkey
Zhaolun Cai, West China Hospital of Sichuan University, China
Ernest Ramsay Camp, Medical University of South Carolina, USA
Riccardo Caccialanza, Hospital Foundation IRCCS Policlinico San Matteo, Italy
Guoxiang Cai, Fudan University Shanghai Cancer Center, China
Kailin Cai, Huazhong University of Science and Technology, China
David Cantu-de Leon, National Cancer Institute, Mexico
Dedong Cao, Wuhan University, China
Wei Cao, Shanghai Jiao Tong University, China
Claudia Cardone, Università degli Studi Luigi Vanvitelli, Italy
Darren Carpizo, Rutgers Cancer Institute of New Jersey, USA
Dirce Maria Carraro, AC Camargo Cancer Center, Brazil
Paolo Casadio, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Francesco Ceci, Universita degli Studi di Torino Dipartimento di Scienze Mediche, Italy
Sakti Chakrabarti, Medical College of Wisconsin, USA
Anindita Chakrabarty, Shiv Nadar University, India
Abhijit Chakraborty, Baylor College of Medicine, USA
Nalini Chandar, Midwestern University, USA
Wen-Wei Chang, Chung Shan Medical University, Taiwan
Yu-Chan Chang, National Yang Ming Chiao Tung University, Taiwan R.O.C.
Sanjib Chaudhary, University of Nebraska Medical Center, USA
Swapna Chaudhuri, School of Tropical Medicine, India
Magdalena Chechlinska, Cancer Centre and Institute of Oncology, Poland
Jinbo Chen, Xiangya Hospital, China
Pai-Sheng Chen, National Cheng Kung University, Taiwan
Xin Chen, University of California San Francisco (UCSF), USA
Yen-Hao Chen, Chang Gung Memorial Hospital, Taiwan
Ann-Joy Cheng, Chang Gung University, Taiwan
Jia Cheng, Zhongshan Hospital of Xiamen University, China
Chih-Yen Chien, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Taiwan
Chun-Ru Chien, China Medical University Hospital, Taiwan
Dai Chihara, The University of Texas MD Anderson Cancer Center, USA
Abhishek Chilkulwar, Saint louis university, USA
Chien-Chih Chiu, Koahsiung Medical University, Taiwan
William Cho, Queen Elizabeth Hospital, Hong Kong
Michal Chovanec, National Cancer Institute, Slovakia
Carl Christofer, Karolinska Institutet, Sweden
Anca Maria Cimpean, Victor Babes University of Medicine and Pharmacy Timisoara, Romania
Carlos Ciudad, University of Barcelona, Spain
Lena-Christin Conradi, University Medical Center Göttingen, Germany
Juan Coelho-Silva, University of Sao Paulo, Brazil
Alice Conigliaro, University of Palermo, Italy
Vincenza Conteduca, Istituto Scientifico Romagnolo per la Cura dei Tumori IRST, Italy
Rachel Conyers, Murdoch Children’s Research Institute, Australia
Katia Cortese, University of Genoa, Italy
Filipe Coutinho, Centro Hospitalar do Médio Ave, Portugal
Li Cui, Southern Medical University, China
Zhaolei Cui, Fujian Medical University Cancer Hospital, China
Margaret Currie, University of Otago Christchurch, New Zealand
Kate Cuschieri, Edinburgh Royal Infirmary, UK
Andrea D'Aviero, Mater Olbia Hospital, Italy
Gabi Dachs, University of Otago, Christchurch, New Zealand
Yataro Daigo, Institute of Medical Science, University of Tokyo, Japan
Edoardo D’Angelo, University of Padova, Italy
Bhudev Das, University of Delhi, India
Subramanyam Dasari, Indiana University, USA
Santanu Dasgupta, University of South Alabama, USA
Richa Dawar, University of Miami/Sylvester Comprehensive Cancer Center, USA
Raffaele De Luca, IRCCS Istituto Tumori "Giovanni Paolo II", Italy
Rita De Sanctis, Humanitas University, Italy
Bo Deng, Daping Hospital, Army Medical University, China
Deandreis Desiree, University of Turin, Italy
Sean Devlin, Memorial Sloan-Kettering Cancer Center, USA
Chiara Di Tucci, Policlinico Umberto Primo "University Sapienza", Italy
Mostafa Dianati-Nasab, Maastricht University, Netherlands
José Díaz-Chávez, Instituto Nacional de Cancerología, México
Manjusha Dixit, NISER, Bhubaneswar, India
Emmy Dolman, Children's Cancer Institute, Australia
Jing Dong, Baylor College of Medicine, USA
Peixin Dong, Hokkaido University, Japan
Michael Doran, Queensland University of Technology at the Translational Research Institute, Australia
Jonathan Dry, Tempus Labs, USA
Fangfang Duan, Sun Yat-sen University Cancer Center, China
Francine Durocher, CHU de Quebec Research Centre-Laval University, Canada
Fabio Efficace, Italian Group for Adult Hematologic Diseases (GIMEMA), Italy
Khalid El Bairi, Mohamed Ist University, Morocco
Eyad Elkord, University of Salford, UK
Mohamedraed Elshami, University Hospitals Cleveland Medical Center, USA
Yakup Ergun, Department of Medical Oncology, Batman Training and Research Hospital, Turkey
A. Emre Eşkazan, Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Turkey
Shahroo Etemad-Moghadam, Tehran University of Medical Sciences, Iran
Ciaran Fairman, Edith Cowan University, Australia
Daniele Fanale, University Hospital Policlinico “P.Giaccone” of Palermo, Italy
Francesco Fanfani, Catholic University, Italy
Hezhi Fang, Wenzhou Medical University, China
Katherina Farr, Aarhus University Hospital, Denmark
Mark Farrugia, Roswell Park Comprehensive Cancer Center, USA
Pietro Di Fazio, Philipps University Marburg, Germany
Wolfgang Fendler, Klinikum der Universität München
Elisabetta Ferretti, University of Rome Sapienza, Italy
Andrés José María Ferreri, IRCCS San Raffaele Scientific Institute, Italy
Bruno Fionda, Saint Camillus International University of Health Sciences, Italy
Agata Filip, Medical University in Lublin, Poland
Panagiota Filippou, Teesside University, United Kingdom
Mohammad Mahdi Forghanifard, Islamic Azad University, Iran
Robert Fruscio, San Gerardo Hospital, Italy
Yutaka Fujiwara, Cancer Center, Japan
Shrikanth Gadad, Texas Tech University Health Sciences Center El Paso, USA
Georgios Gakis, University Hospital of Würzburg, Germany
Filippo Tommaso Gallina, IRCCS Regina Elena National Cancer Institute of Rome, Italy
Gaetano Gallo, Sapienza University of Rome, Italy
Antoine Galmiche, Amiens University Hospital, France
Paolo Gandellini, University of Milan, Italy
Babu Gajendran, Guizhou Medical University, China
Aditya Ganju, Memorial Sloan Kettering Cancer Center, USA
Juehua Gao, University Feinberg School of Medicine, USA
Alejandro Garcia-Carranca, Unidad de Investigación Biomédica en Cáncer, UNAM & INCan, Mexico
Eduardo Garcia-Rico, Hospital Universitario HM Torrelodones, Spain
Manoj Garg, Amity University Uttar Pradesh, India
Giorgia Garganese, Gynecology And Breast Care Center, Mater Olbia Hospiital, Catholic University Of The Sacred Heart, Italy
Yubin Ge, Wayne State University School of Medicine, USA
Timo Gemoll, University of Lübeck, Germany
Nebu Abraham George, regional cancer centre, India
Arnab Ghosh, Memorial Sloan Kettering Cancer Center, USA
Luca Giannella, Polytechnic University of Marche, Italy
Spencer B Gibson, University of Manitoba, Canada
Mar Giner-Calabuig, Yale University, USA
Elisa Giovannetti, VU University Medical Center, Netherlands
Frederico Gleber-Netto, The University of Texas MD Anderson Cancer Center, USA
John Go, University of Southern California, USA
Radhika Gogoi, Wayne State University, Karmanos Cancer Institute, USA
Erica Golemis, Fox Chase Cancer Center, USA
Soehartati Gondhowiardjo, Cipto Mangunkusumo National Hospital, Indonesia
Anilkumar Gopalakrishnapillai, Alfred I duPont Hospital for Children, USA
Akiteru Goto, Akita University, Japan
Claudia Gravekamp, Albert Einstein College of Medicine, USA
Steven Gray, St James’s Hospital, Ireland
Giovanni Grignani, Candiolo Cancer Institute-FPO- IRCCS, Italy
Christoph Grimm, Medical University of Vienna, Austria
Jeffery Groce, The Ohio State University, USA
Yu Gu, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, China
Elia Guadagno, Università degli Studi di Napoli Federico II, Italy
Wu Guangzhen, First Affiliated hospital of Dalian Medical University, China, People's Republic
Emer Guinan, Trinity College Dublin, Ireland
Kemal Güngördük, Mugla Sıtkı Kocman University Education and Research Hospital, Turkey
Xingyi Guo, Vanderbilt University Medical Center, USA
Zong Sheng Guo, University of Pittsburgh, USA
Jalaj Gupta, Stem Cell Research Center (SCRC) and Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), India
Romi Gupta, The University of Alabama at Birmingham, USA
Simona Gurzu, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology, Targu Mures, Romania
Deniz Can Güven, Hacettepe University Cancer Institute, Turkey
Christel Häggström, Umeå University, Department of Public Health and Clinical Medicine, Sweden
Daniel Halperin, MD Anderson Cancer Center, USA
Yasuo Hamamoto, Keio University School of Medicine, Japan
Chisato Hamashima, National Cancer Center, Japan
Sun-Young Han, Gyeongsang National University, South Korea
Jitti Hanprasertpong, Prince of Songkla University, Thailand
Fumiakta Hara, The Cancer Institute Hospital of JFCR, Japan
Andreas Hartkopf, Department of women's health, University of Tuebingen, Germany
Arndt Hartmann, Institute of Pathology, Erlangen, Germany
Matthias G Hautmann, University Hospital Regensburg, Germany
 Jeffrey Hawley, Wexner Medical Center at the Ohio State University, USA
Bangshun He, Nanjing First Hospital, Nanjing Medical University., China
Hongyong He, Zhongshan Hospital, Fudan University, China
Rong-Rong He, Jinan University, China
Wen-zhuo He, Sun Yat-sen University Cancer Center, China
Yazhou He, University of Edinburgh, UK, and West China School of Public Health, Sichuan University, China
Wilma Heemsbergen, Erasmus MC Cancer Institute, Netherlands
Rakesh Heer, Imperial College London, United Kingdom
Khalil Helou, Gothenburg University, Sweden
Otto Hemminki, University of Helsinki, Finland
André Hennigs, Heidelberg University Hospital, Germany
Zoltan Herold, Semmelweis University, Hungary
Yoon Ho Ko, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, South Korea
Adrien Holzgreve, Department of Nuclear Medicine, University Hospital, LMU Munich, Germany
Xin Hong, Southern University of Science and Technology, ShenZhen, China
Yongcheng Hu, Tianjin Hospital, China
Xin Hua, Ruijin Hospital, Shanghai Jiaotong University, China
Shu-Hong Huang, Shandong First Medical University, China
Xing Huang, Zhejiang University School of Medicine, China
Mieke Van Hemelrijck, King's College London, UK
Brittney-Shea Herbert, Indiana University School of Medicine, USA
Eason Hildreth, University of Alabama at Birmingham (UAB), USA
Arnold Hill, Royal College of Surgeons in Ireland, Ireland
Robert Hines, University of Central Florida College of Medicine, USA
Noriyuki Hirahara, Shimane University Faculty of Medicine, Japan
Kenji Hirata, Hokkaido University, Japan 
Jeffrey Hoch, University of California, Davis, USA
Bryan Holcomb, Indiana University School of Medicine, USA
Jeff Holst, University of New South Wales, Australia
Andrew Hoy, University of Sydney, Australia
Jason Chia-Hsun Hsieh, Chang Gung Memorial Hospital at Linkou, and New Taipei Municipal TuCheng Hospital, Taiwan
Yan Hu, Second Xiangya Hospital of Central South University, China
Jing Huang, National Cancer Institute, National Institutes of Health, USA
Tim Hulsen, Philips Research, Netherlands
Michael Hummel, Charité - Berlin, Germany
Teh-Ia Huo, Taipei Veterans General Hospital, Taiwan R.O.C.
Deema Hussein, King Abdulaziz University, Saudi Arabia
Harun Ilhan, Ludwig Maximilians University of Munich, Germany
Saber Imani, Shulan International Medical College, Zhejiang Shuren University, China
Marco Invernizzi, University of Eastern Piedmont, Italy
Masaoki Ito, Kindai University, Japan
Aakanksha Jain, Boston Children's Hospital, USA
Scharukh Jalisi, Beth Israel Deaconess Medical Center/ Harvard Medical School, USA
Bum-Sup Jang, Seoul National University Hospital, Republic of South Korea
Kyu Yun Jang, Jeonbuk National University Medical School, Korea, Republic of South Korea​​​​​​
Filip Janku, University of Texas MD Anderson Cancer Center, USA
Frank Jansman, University Groningen, Netherlands
Stefan Janssen, University of Lübeck, Department of Radiation Oncology, Germany
Bruno Bernardes de Jesus, iBiMED - Institute of Biomedicine, University of Aveiro, Portugal
Jianguang Ji, Lund University, Sweden
Aimin Jiang, The First Affiliated Hospital of Xi'an Jiaotong University, China
Moonsoo M. Jin, Weill Cornell Medical College, USA
Goodwin Jinesh, Moffitt Cancer Center, USA
Ji Hoon Jung, Kyung Hee University, Korea, Republic of (South Korea)
Ranjana Kanchan, University of Nebraska Medical Center, USA
Raghuram Kandimalla, University of Louisville, USA
Chunsheng Kang, Tianjin Medical University General Hospital, China
Cengiz Karacin, Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Turkey
Sophia N Karagiannis, King's College London, UK
Omer Faruk Karatas, Erzurum Technical University, Turkiye
Saswati Karmakar, Stanford University, USA
Kinyas Kartal, Koc University, Turkey
Hiroaki Kasashima, Osaka Metropolitan University, Japan
Manoj Kashyap, Amity University Haryana, India
Lukas Käsmann, Department of Radiation Oncology, LMU University Hospital, Munich, Germany
Mandeep Kaur, University of the Witwatersrand, South Africa
Imran Khan, The Hormel Institute, USA
Zhihua Kang, Rutgers Cancer Institute of New Jersey, Rutgers University, USA
Eva Kantelhardt, Martin-Luther-University Halle-Wittenberg, Germany, Germany
Vivek Kashyap, University of Texas Rio Grande Valley, Texas, USA
Hee Seung Kim, Seoul National University College of Medicine, Korea
Nakarin Kitkumthorn, Faculty of Dentistry, Mahidol University, Thailand
Roman Kloeckner, University Medical Center of the Johannes Gutenberg-University Mainz, Germany
Yasuhiro Koh, Wakayama Medical University, Japan
Daisuke Komura, The University of Tokyo, Japan
Prathyusha Konda, Dana-Farber Cancer Institute, USA
Ramez Kouzy, University of Texas MD Anderson Cancer Center, USA
Artur Kowalik, Holycross Cancer Center, Poland
Aya Kuchiba, National Cancer Center, Japan
Arutha Kulasinghe, Queensland University of Technology, Australia
Rahul Kumar, Indian Institute of Technology, India
Vinit Kumar, Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, India
Hidekazu Kuramochi, Tokyo Women's Medical University, Japan
Özgür Kutuk, Baskent University, Turkey
Melissa LaBonte Wilson, Queen's University Belfast, UK
Morten Ladekarl, Aalborg University Hospital, Denmark
Sjoerd Lagarde, Erasmus MC, University Medical Centre, Netherlands
Ka-On Lam, The University of Hong Kong, Hong Kong SAR
Valentina Lancellotta, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Italy
Anne Laprie, IUCT-oncopole, France
Saeid Latifi-Navid, University of Mohaghegh Ardabili, Iran
Rossano Lattanzio, “G. d’Annunzio” University – Center for Advanced Studies and Technology (CAST), Italy
Marianna Lauricella, University of Palermo, Italy
Monika Lejman, Medical University of Lublin, Poland
Andreia Leopoldino, University of São Paulo, Brazil
Haoran Li, University of Kansas Cancer Center, USA
Li Li, The University of Queensland, Australia
Ming Li, Zhongshan Hospital, Fudan University, China
Tian Li, Fourth Military Medical University, China
Wang-Zhong Li, National Clinical Research Center for Respiratory Disease and the Department of Thoracic Surgery, the First Affiliated Hospital of Guangzhou Medical University, China
Zaibo Li, Ohio State University Wexner Medical Center, USA
Bertrand Liagre, University of Limoges, Faculty of Pharmacy, Head of Department of Biochemistry and Molecular Biology, France
Jiaqi Liang, Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, China
Rui Liao, The First Affiliated Hospital of Chongqing Medical University, China
Wei Yu Liao, National Taiwan University College of Medicine, Taiwan R.O.C.
Leonardo Lino-Silva, National cancer institute (Mexico) INCan, Mexico
Gabor Liposits, University of Southern Denmark, Denmark
Bin Liu, The University of Arizona, USA
Chao Liu, Shandong Cancer Hospital, China
Jinhui Liu, The First Affiliated Hospital of Nanjing Medical University, China
Xiangliang Liu, The First Hospital of Jilin University, China
Zhihui Liu, National Cancer Institute, USA
Paul Lockman, West Virginia University, USA
Filippo Lococo, Foundation Policlinico Universitario Agostino Gemelli IRCCS, Italy
Priya Londhe, Tufts Medical Center, USA
Herbert Loong, The Chinese University of Hong Kong, Hong Kong SAR
Cesar Lopez-Camarillo, Universidad Autónoma de la Ciudad de México, Mexico
Claudio Luchini, University of Verona, Italy
Kiven Erique Lukong, University of Saskatchewan, Canada
Lianxiang Luo, Guangdong medical university, China
Weiren Luo, The Second Affiliated Hospital of Southern University of Science and Technology, China
Chenkai Ma, CSIRO, Australia
Sung Jun Ma, Roswell Park Comprehensive Cancer Center, USA
Anant Madabhushi, Emory University, USA
Vijay Sagar Madamsetty, Mayo Clinic, USA
Andrea Mafficini, University and Hospital Trust of Verona, Italy
Marcello Maggiolini, University of Calabria, Italy
Chiyoko Makita, Gifu University, Japan
Parmanand Malvi, UAB Department of Biochemistry and Molecular Genetics, USA
Joshua Mammen, University of Kansas, USA
Chandi C. Mandal, Central University of Rajasthan, India
Vishnu R Mani, Columbia University College of Physicians and Surgeons at Harlem Hospital Center, USA
Alak Manna, Moffitt Cancer Center, USA
Alak Manna, Mayo Clinic, USA
Venkata Manem, Quebec Heart and Lung Institute Research Center/Laval University, Canada
Ning Mao, Yantai Yuhuangding Hospital, China
Wenjun Mao, The Affiliated Wuxi People’s Hospital of Nanjing Medical 12 University, China
Luigi Marano, University of Siena, Italy
Virginie Marcel, Cancer Research Center Lyon (CRCL), France
Vitaly Margulis, The University of Texas Southwestern Medical Center, USA
Catherine Marinac, Dana-Farber Cancer Institute and Harvard Medical School, USA
Daniele Marinelli, Sapienza University, Italy
Erina Marshall, BC Cancer Research Centre, Canada
Maurizio Martini, Università Cattolica del Sacro Cuore, Italy
Samip Master, Louisiana State University Health Sciences Center, USA
Khalid Matalka, OncoTherapeutica, Inc., USA
Junichi Matsubara, Kyoto University Graduate School of Medicine, Japan
Fabrizio Mattei, Istituto Superiore di Sanità, Italy
 Guillermo Mazzolini, Austral University-Conicet, Argentina 
Simon McDade, Queen's University Belfast, UK
Charlene McShane, Queen’s University Belfast, UK
Stuart McIntosh, Queen's University Belfast, UK
Michal Mego, Comenius University, Medical Faculty, Slovakia
Jie Mei, Nanjing Medical University, China
Zubing Mei, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, China
Markus Meissner, Goethe University Frankfurt, Germany
Florence Menegaux, INSERM - French National Institute of Health and Medical Research, France
Giulio Metro, Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Italy
Eric Metzen, University of Duisburg-Essen, Germany
Michael Michael, Peter MacCallum Cancer Centre, Australia
Evelina Miele, Bambino Gesù Children's Hospital, Italy
Gustavo Miranda-Carboni, UTHSC, USA
Sandip Mishra, Institute of Life Sciences, India
Sanjay Mishra, Brown University, USA
Nikol Mladkova, Mount Sinai, USA
Amr Mohamed, UH Seidman Cancer Center, USA
Mikito Mori, International University of Health and Welfare Ichikawa Hospital, Japan
Kenji Morimoto, Kyoto Prefectural University of Medicine, Japan
Toshitaka Morishima, Osaka International Cancer Institute, Japan
Hamid Morjani, University of Reims, France
Naoshad Muhammad, Washington University in Saint Louis, USA
Sudip Mukherjee, Rice University, USA
Subhadip Mukhopadhyay, New York University Langone Health, USA
Karthikeyan Murugesan, Foundation Medicine Inc., USA
Tateaki Naito, Shizuoka Cancer Center, Japan
Tomoki Nakamura, Mie University, Japan
Kentaro Nakayama, Shimane University, Japan
Dhanya Nambiar, Stanford University, USA
Camilla Nero, Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy
Daniel Neureiter, Paracelsus Medical University, Austria
Quan Nguyen, The University of Queensland, Australia
Chiara Nicolazzo, Sapienza University of Rome, Zimbabwe
Nikita Nikita, Thomas Jefferson University , USA
Sisse Helle Njor, Department of Public Health Programmes, Denmark
Bo Nordman, Erasmus MC, University Medical Centre, Netherlands
Nicola Normanno, ITN-Fondazione Pascale, Italy 
George Notas, University of Crete School of Medicine, Greece
Dominic O’Connor, University of Nottingham, UK
Mairead O’Connor, The National Screening Service, Ireland
Takaaki Oba, Shinshu Universty, Japan
Junya Oguma, National Cancer Center Hospital, Japan
Eok-Soo Oh, Ewha Womans University, South Korea
Susumu Okano, National Cancer Center Hospital East, Japan
Timothee Olivier, Geneva University Hospital, Switzerland
Cem Onal, Baskent University Faculty of Medicine, Turkey
Wee Loon Ong, Monash University, Australia
Francesca Orso, University of Torino, c/o Molecular Biotechnology Center, Italy
Chunlin Ou, Xiangya Hospital, Central South University, China
Medhi Ouaïssi, Trousseau Hospital, France
Yuichi Ozawa, Hamamatsu Medical Center, Japan
Enis Ozyar, Acibadem MAA University, Turkey
Frank Pajonk, University of California San Francisco (UCLA), USA
Tejinder Pal, Stanford University, USA
Dario Palmieri, The Ohio State University, USA
Manoj Pandey, Penn Stat Hershey Medical Center, USA
Cristina Papayannidis, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Ila Pant, Icahn School of Medicine at Mount Sinai, USA
Piero Papi, “Sapienza” University of Rome, Italy
Deepak Parashar, Medical College of Wisconsin, USA
Fresia Pareja, Memorial Sloan Kettering Cancer Center, USA
Toshima Parris, University of Gothenburg, Sweden
Seema Parte, University of Nebraska Medical Center, USA
Akash Patel, Baylor College of Medicine, USA 
Anup Pathania, University of Nebraska Medical Center, Omaha, NE, USA
Jijo Paul, Medical College of Wisconsin, USA
Manash Paul, University of California Los Angeles, USA
Corrado Pedrazzani, Verona University, Italy
Marco Pellegrini, Consiglio Nazionale delle Ricerche, Italy
Roberto Peltrini, University of Naples Federico II, Italy
Aimin Peng, University of Nebraska Medical Center, USA
Gao Peng, The First Hospital of China Medical University, China
Diego de Miguel Perez, University of Maryland School of Medicine, USA
Manuel Perucho, The Burnham Institute, USA
Stefano Petti, Sapienza University, Italy
Georg Pfeiler, Medical University of Vienna, Austria
Roberto Pippi, Sapienza University of Rome, Italy
Daniele Pironi, Sapienza University of Rome, Italy
Pasquale Pisapia, University of Naples Federico II, Italy
Stephan Polterauer, Comprehensive Cancer Center Vienna, Medical University of Vienna, Austria
Georgios Polychronidis, Harvard School of Public Health, USA
Bernard Pope, The University of Melbourne, Australia
Ramesh Pothuraju, University of Nebraska Medical Center, USA
Tomasz Powrózek, Medical University of Lublin, Poland
Anjan Pradhan, Virginia Commonwealth University, USA
Joseph Pressey, Cincinnati Children’s Hospital Medical Center, USA
Alessandro Provenzani, CIBIO, University of Trento, Italy
Joan-Anton Puig, Hospital Clinic de Barcelona, Spain
Chamindie Punyadeera, Griffith University, Australia
Jin Qian, Stanford University, USA
Ya-Wei Qiang, University of Arkansas for Medical Sciences, USA
Liang Qiao, University of Sydney, Australia
Jiayue Qin, Acornmed Biotechnology Co., Ltd., China
Fuman Qiu, Guangzhou Medical University, China
Dirk Rades, University Hospital Schleswig-Holstein, Germany
Antonio Raffone, University of Naples Federico II, Italy
Max Carlos Ramírez-Soto, Universidad Peruana Cayetano Heredia, Peru
Brian Ramnaraign, University of Florida, USA
Jacques Raphael, London Regional Cancer Program, Canada
Gloria Ravegnini, University of Bologna, Italy
Upasana Ray, MD Anderson Cancer Center, USA
Matejka Rebolj, University of Copenhagen, Denmark
Alaa Refaat, National University of Ireland Galway, Ireland
Daniel Reim, TUM School of Medicine,, Germany
Bharat Rekhi, Tata Memorial Hospital, Parel, Mumbai, India
Cielito C Reyes-Gibby, University of Texas MD Anderson Cancer Center, USA
Hamid Reza Mirzaei, Tehran University of Medical Sciences, Iran
Günther Rezniczek, Ruhr-Universität Bochum, Germany
Carmela Ricciardelli, Univeristy of Adelaide, Australia
Girdhari Rijal, Tarleton State University, A member of the Texas A & M University System, USA
Flavio Rizzolio, Ca' Foscari University of Venice, Italy
Brian Robinson, New York Presbyterian Hospital, USA
Augusto Rojas-Martinez, Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico
Atocha Romero, Hospital Puerta de Hierro, Spain
Fausto Rosa, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy
Camiel Rosman, Radboud university medical center Nijmegen, Netherlands
Helen Ross-Adams, Barts Cancer Institute, Queen Mary University of London, United Kingdom
Adrien Rossary, Université Clermont Auvergne - INRAE, France
Giandomenico Roviello, University of Florence, Italy
Thomas Ruhstaller, Cantonal Hospital of St. Gallen, Switzerland
Andrea Ruzzenente, University of Verona, Italy
Annamaria Ruzzo, University of Urbino, Italy
Maja Sabol, Ruđer Bošković Institute, Croatia
Birendra Sah, Ruijin Hospital Affiliated to Shanghai Jiaotong University, China
Animesh Saha, Apollo Gleneagles Cancer Hospital, Kolkata, India
Biswarup Saha, H Lee Moffitt Cancer Center & Research Institute, USA
Özgür Sahin, University of South Carolina, USA
Vinay Sagar, Feinberg School of Medicine, Northwestern University, USA
Yasunaru Sakuma, Jichi Medical Unversity, Japan
Rémy Salmon, GCS Saint Jean de Dieu, France
Maureen Sanderson, Meharry Medical College, USA
Dipak Sapkota, University of Oslo, Norway
Chandrani Sarkar, University of South Alabama, USA
Gangadhara Reddy Sareddy, University of Texas, USA
Kienan Savage, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast, UK
Douglas Sborov, University of Utah, Huntsman Cancer Institute, USA
Roberto Scatena, Catholic University of Rome /M.G. Vannini hospital, Italy
Matthew B Schabath, H. Lee Moffitt Cancer Center and Research Institute, USA
Eva Schernhammer, Brigham and Women's Hospital and Harvard Medical School, USA
Fernando Schmitt, IPATIMUP - University of Porto, Portugal
Mirela Sedic, University of Rijeka, Croatia
Violaine Sée, Université Claude Bernard Lyon 1, France
Eva Segelov, University of Bern and University Cancer Centre, Inselspital, Switzerland
Sanjeewa Seneviratne, Department of Surgery, University of Colombo, Sri Lanka, Sri Lanka
Mukund Seshadri, Roswell Park Comprehensive Cancer Center, USA
Arun Seth, University of Toronto and Sunnybrook Health Sciences Centre, Canada
Gautam Sethi, National University of Singapore, Singapore
Vidyalakshmi Sethunath, Foundation Medicine., Inc., USA
Ali Shamseddine, American University of Beirut Medican center, Lebanon
Anand Sharma, Mount Vernon Cancer Centre, United Kingdom
Gaurav Sharma, University of Texas Southwestern Medical Center at Dallas, USA
Tanveer Ahmad Sheikh, St. Jude Children Research Hospital, USA
Malathy Shekhar, Wayne State University School of Medicine, USA
Jie Shen, University of Virginia, USA
Huashan Shi, Shichuan University, China
Aesun Shin, Seoul National University, South Korea
Mark Shiroishi, USC, USA
Aditya Shreenivas, Medical College of Wisconsin, USA  
 Xiang Shu, Memorial Sloan Kettering Cancer Center, USA
Samriddhi Shukla, Cincinnati Children's Hospital Medical Center, USA
Sudhanshu Shukla, Indian Institute of Technology Dharwad, India
Takehito Shukuya, Juntendo University, Japan
Christina Signorelli, UNSW Sydney, Australia
Jin-Ah Sim, St.Jude Children’s Research Hospital, USA
Rajesh Singh, Morehouse School of Medicine, USA
Santosh Singh, Morehouse School of Medicine, USA
Shwetabh Sinha, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, India
Kathryn Skelding, University of Newcastle, Australia
Szymon Skoczen, Jagiellonian University Medical  College, Poland
Robert Smith, University of Macau, Macao SAR, China
Hugo Sousa, IPO Porto FG, EPE, Portugal
Benjamin Spieler, University of Miami, USA
Ramaprasad Srinivasan, National Cancer Institute, USA
Eike Staub, Merck Healthcare KGaA, Germany
Cristina Stefan, IGHER, Rwanda
Eric Steiner, GPR Clinical Centre, Germany
Lucia Anna Stivala, University of Pavia, Italy
Carmen Stromberger, Charité – Universitätsmedizin Berlin, Germany
Elavarasan Subramani, The University of Texas M.D. Anderson Cancer Center, USA
Chengcao Sun, Wuhan University, China
Kun Sun, Shenzhen Bay Laboratory, China
Ping-Li Sun, The Second Hospital of Jilin University, China
Chitra Subramanian, University of Michigan, USA
Yun-Suhk Suh, Seoul National University Bundang Hospital, Korea
Ruping Sun, University of Minnesota, USA
Zhifu Sun, Mayo Clinic, USA
Shi-Yong Sun, Emory University, USA
Debasish Sundi, The University of Texas, USA
Erin Symonds, Flinders Medical Centre, Australia
Nicholas Syn, National University of Singapore, Yong Loo Lin School of Medicine, Singapore
Farzad Taghizadeh-Hesary, Shahid Beheshti University of Medical Sciences, Iran
Kazuki Takada, Saiseikai Fukuoka General Hospital, Japan
Masahiro Takada, Kyoto University Graduate School of Medicine, Japan
Namiatsu Takahara, University of Tokyo Hospital, Japan
Hidekazu Takahashi, Osaka Police Hospital, Japan
Akihiko Takeuchi, Kanazawa University, Japan
Ryota Tamura, Keio University School of Medicine, Japan
Xiaohu Tang, Michigan Technological University, USA
Xiuwen Tang, Zhejiang University School of Medicine, China
Pranay Tanwar, AIIMS, India
Yongguang Tao, Cancer Research Institute of Central South University, China
Clayton Taylor, The Ohio State University Wexner Medical Center, USA
Xinzhi Teng, The Hong Kong Polytechnic University, Hong Kong SAR
Paweł Teterycz, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
 Shilpa Thakur, National Institutes of Health, USA
Kyaw Thein, Oregon Health and Science University/ Knight Cancer Institute, USA
Marieta Toma, University Clinic Bonn, Germany
Bastiaan Tops, Prinses Maxima Centrum, Netherlands
Masayuki Tori, Hyogo College of Medicine and Osaka Police Hospital, Japan
Maria Lina Tornesello, Istituto Nazionale Tumori IRCCS Fond Pascale, Italy
Gary Tozbikian, The Ohio State University Wexner Medical Center, USA
Marija Trajkovic-Arsic, DKFZ/DKTK Essen, Germany
Nham Tran, University of Technology Sydney, Australia
Antonio Travaglino, Federico II University of Naples, Italy
Masayuki Tsuneki, Medmain Inc., Japan
Yasuhiro Tsutani, Hiroshima University, Japan
Chao Tu, The Second Xiangya Hospital, Central South University, China
Bufu Tang, Fudan University Zhongshan Hospital, China
Gulisa Turashvili, Emory University Hospital, USA
Giulia Turri, University of Verona, Italy
Clara Ugolini, University of Pisa, Italy
Luca Urso, S. Maria della Misericordia Hospita, Italy
Hironori Uruga, Toraomon Hospital, Japan
Caroline Vandeputte, Jules Bordet Institute, Belgium
Kate Vandyke, University of Adelaide, Australia
Folkert Van Kemenade, Erasmus MC Univ Medical Center, The Netherlands
Athanassios Vassilopoulos, Northwestern University, USA
Francesco Vasuri, Azienda Ospedaliero-Universitaria di Bologna, Bologna University Hospital, Italy
Ioannis Vathiotis, National and Kapodistrian University of Athens, Greece
Antonello Veccia, Medical Oncology, Santa Chiara Hospital of Trento, Italy
Omkara Lakshmi Veeranki, University of Texas, USA
Kiran Velpula, University of Illinois College of Medicine, USA
Vyshak Venur, Fred Hutchinson Cancer Center/University of Washington, USA
Massimiliano Veroux, University Hospital of Catania, Italy
Gregoru Vidal, West Cancer Center and Research Institute, USA
Davide Vigetti, University of Insubria, Italy
Namrata Vijayvergia, Fox Chase Cancer Center, USA
Bruno Vincenzi, University Campus Bio-Medico, Italy
Satish Viswanath, Case Western Reserve University, USA
Caterina Vivaldi, University of Pisa, Italy
Giuseppe Vizzielli, “ Agostino Gemelli” University Hospital, IRCCS, Italy
Erina Vlashi, UCLA College of Life Sciences, USA
Alina Vrieling, Radboud university medical center, Netherlands
Huy Vuong, University of Iowa Hospitals and Clinics, USA
Markus W. Löffler, University of Tübingen, Germany
Kay-Uwe Wagner, University of Nebraska Medical Center, USA
Sébastien Wälchli, Oslo Cancer Cluster Incubator, Norway
Iris Walraven, Department for Health Evidence, Radboudumc, Netherlands
Andrew Wang, UT Southwestern, USA
Dong Wang, Chengdu University of Traditional Chinese Medicine, China
Fu Wang, Xi'an Jiaotong University, China
Haiwei Wang, Fujian Maternity and Child Health Hospital, China
Hua Wang, Rockefeller Research Labs (MSK), USA
Huan-You Wang, University of California San Diego, USA
Jiayin Wang, Xi’an Jiaotong University, China
Tong-Min Wang, Sun Yat-sen University Cancer Center, China
Zhanwei Wang, University of Hawaii Cancer Center, USA
Zhen-Ning Wang, The First Hospital of China Medical University, China
Sudha Warrier, Manipal Academy of Higher Education, India
Junichiro Watanabe, Juntendo University Graduate School of Medicine, Japan
Manuel Weber, Mund-, Kiefer- und Gesichtschirurgische Klinik, Germany
Runmin Wei, The University of Texas MD Anderson Cancer Center, USA
Shuanzeng Wei, Fox Chase Cancer Center, USA
Olga Weinberg, UT Southwestern Medical Center, USA
Geoffrey Weiss, University of Virginia Health System, USA
Armin Wiegering, University Hospital of Wuerzburg, Germany
Joachim Widder, Medical University of Vienna, Austria
Chiao-En Wu, Chang Gung Memorial Hospital, Linkou, Taiwan R.O.C
Lang Wu, University of Hawaiʻi at Mānoa, USA
Licun Wu, Toronto General Hospital, University Health Network, Canada
Shuai Wu, The Wistar Institute, USA
Zhijia Xia, Ludwig-Maximilians-University Munich, Germany
Wa Xian, UT Health, USA
Xiaojun Xiang, The First Affiliated Hospital of Nanchang University, China
Yu-Dong Xiao, the Second Xiangya Hospital of Central South University, China
Congying Xie, Wenzhou Medical University 2nd Affiliated Hospital, China
Haineng Xu, University of Pennsylvania, USA
Jie Xu, Fudan University, China
Yingkun Xu, Chongqing Medical University, China
Pengcheng Xun, Indiana University, USA
Vasily Yakolov, VCU Massey Cancer Center, USA
Hiroharu Yamashita, Graduate School of Medicine, The University of Tokyo, Japan
Li Yan, EENT Hospital, Fudan University, China
Fei Yang, University of Miami School of Medicine, USA
Lin Yang, Alberta Health Services, Canada
Shun-Fa Yang, Chung Shan Medical University, Taiwan
Wei Yang, Soochow University, China
Justin Yeung, University of Melbourne, Australia
John Yim, Beckman Research Institute of City of Hope, USA
Changhoon Yoo, Asan Medical Center, South Korea
Akira Yoshida, International University of Health and Welfare, Japan
Chaoran Yu, Shanghai Jiao Tong University School of Medicine, China
Jian Yu, Beihang University, China
Yan Yuanliang, Xiangya Hospital, Central South University, China
Fei Yue, Baylor College of Medicine, USA
Chae-Ok Yun, Yonsei University College of Medicine, South Korea
Arseniy Yuzhalin, The University of Texas MD Anderson Cancer Center, USA
Peter Zage, University of California San Diego, USA
Hadi Zamanian, Qom University of Medical Sciences, Iran
Apostolos Zaravinos, European University Cyprus, Cyprus
Ke Zhao, Guangdong Provincial People’s Hospital, China
Cheng Zhan, Fudan University, China
Chun-Dong Zhang, The Fourth Affiliated Hospital of China Medical University, China
Hao Zhang, The Second Affiliated Hospital, Chongqing Medical University, China
Jianjun Zhang, Indiana University, USA
Ling Zhang, Moffitt Cancer Center, USA
Qiongwen Zhang, West China Hospital, China
Wen Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Wensheng Zhang, Xavier University of Louisiana, USA
Xiaotao Zhang, Baylor College of Medicine, USA
Yongchang Zhang, Hunan Cancer Hospital, China
Yongchao Zhao, Zhejiang University School of Medicine, China
Hua-chuan Zheng, China Medical University, China
Shutao Zheng, the First Affiliated Hospital of Xinjiang Medical University, China
Xu Zhijie, Xiangya Hospital, Central South University, China
Meng Zhou, Wenzhou Medical University, China
Jiaan Zhu, Beijing University/Peking University, China
Hong Zhu, University of Texas Southwestern Medical Center, USA
Debra Zynger, The Ohio State University Medical Center, USA

Editorial Advisors
Mariano Barbacid, Centro Nacional de Investigaciones Oncologicas, Spain
Frederick A Beland, National Center for Toxicological Research, USA
Andrew Bergen, SRI International, USA
Anton Berns, Netherlands Cancer Institute, Netherlands
Maria Blasco, Spanish National Cancer Institute Madrid, Spain
Burkhard Brandt, Universitätsklinikum Hamburg-Eppendorf, Germany
Joan S Brugge, Harvard University, USA
Lewis Cantley, Harvard Institutes of Medicine, USA
Seth J Corey, Northwestern University, USA
Jack Cuzick, Queen Mary's School of Medicine and Dentistry, UK
Shoukat Dedhar, BC Cancer Agency, Canada
Susan Domchek, University of Pennsylvania, USA
William Gallagher, UCD Conway Institute, University College Dublin, Ireland
Paul A Edwards, Cambridge University, UK
Matthew Ellis, Washington University in St. Louis, USA
Gerard Evan, University of California, USA
Ian Frazer, University of Queensland, Australia
Henry S Friedman, Duke University Medical Center, USA
Gustav Gaudernack, The Norwegian Radium Hospital, University of Oslo, Norway
John A Hartley, University College London, UK
Nick Hastie, Western General Hospital, UK
Toshio Hirano, Osaka University Graduate School of Medicine, Japan
Ahmedin Jemal, American Cancer Society, USA
Christopher Kane, Pfizer Inc., USA
Karla Kerlikowske, University of California, USA
Peter Lansdorp, British Columbia Cancer Agency, Canada
Ralph J Lelle, Muenster University, Germany
Michael C MacLeod, University of Texas/ M.D. Anderson Cancer Center, USA
Frank McCormick, University of California, USA
Linda Z Penn, Princess Margaret Hospital, Ontario Cancer Institute, Canada
Jerome Posner, Memorial Sloan-Kettering Cancer Center, USA
Kathy Pritchard-Jones, Royal Marsden Hospital & Institute of Cancer Research, UK
William Rom, New York University School of Medicine, USA
Darryl Shibata, Keck School of Medicine, University of Southern Carolina, USA
Steven D Stellman, Mailman School of Public Health, Columbia University, USA
David Stokoe, University of California, USA
Barbara Vanderhyden, University of Ottawa, Canada
Andrew Vickers, Memorial Sloan-Kettering Cancer Center, USA
Satish Viswanath, Case Western Reserve University, USA
Frederic M Waldman, University of California, USA
Denys Wheatley, BioMedES, UK
Susie Wilkinson, Royal Free & University College Medical School, UK
James Woodgett, Samuel Lunenfeld Research Institute, Canada 

Statistical Advisors
Noori Akhtar-Danesh, McMaster University, Canada
Marisa  Baré, Institut Universitari Parc Taulí, Spain
Guy Brock, University of Louisville, USA
Justin C Brown, Dana-Farber Cancer Institute, USA
Marinela Capanu, Memorial Sloan Kettering Cancer Center, USA
Magdalena Castro Cruz, Clínica las Condes, Chile
Kumardeep Chaudhary, Icahn School of Medicine at Mount Sinai - New York City, NY, USA
Leslie Cope, Johns Hopkins University, USA
Giuliana Cortese, University of Padova, Italy
Feng Gao, Washington University School of Medicine, USA
Sophie Gourgou, Institut Regional du Cancer, France
Chindo Hicks, University of Mississippi Medical Center, USA
YenYi Ho, University of Minnesota, USA
Chi-Cheng Huang, Taipei Veterans General Hospital, Taiwan R.O.C.
Peng Huang, Johns Hopkins Medicine, USA
John Hughes, UK
George A. Kelley, West Virginia University, USA
Sungjin Kim, Cedars-Sinai, USA
Caroline Mollevi, Institut du Cancer de Montpellier, France
John Frederick Pearson, University of Otago, New Zealand
Alex Sánchez-Pla, University of Barcelona, Spain
Brent Jay Shelton, University of Kentucky College of Public Health, USA
Jin-ah Sim, St. Jude Children’s Research Hospital, USA
Rainer Spang, Universität Regensburg, Germany
Christopher Stevenson, Deakin University, Australia
Elizabeth A Sugar, Johns Hopkins Bloomberg School of Public Health, USA
Dawen Sui, The University of Texas MD Anderson Cancer Center, USA
Matthew Truong, University of Rochester, USA
Hao Wang, Johns Hopkins Medicine, USA
Wenyi Wang, The University of Texas MD Anderson Cancer Center, USA

Annual Journal Metrics

  • 2022 Citation Impact
    3.8 - 2-year Impact Factor
    4.3 - 5-year Impact Factor
    1.166 - SNIP (Source Normalized Impact per Paper)
    1.137 - SJR (SCImago Journal Rank)

    2022 Speed
    9 days submission to first editorial decision for all manuscripts (Median)
    148 days submission to accept (Median)

    2022 Usage 
    11,097 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal